Mesenchymal Stem Cell–Sourced Exosomes as Potentially Novel Remedies for Severe Dry Eye Disease DOI Creative Commons

Carl Randall Harrell,

Valentin Djonov, Ana Volarevic

и другие.

Journal of Ophthalmology, Год журнала: 2025, Номер 2025(1)

Опубликована: Янв. 1, 2025

Severe dry eye disease (DED) is an inflammatory condition characterized by a lack of sufficient moisture or lubrication on the surface eye, significantly impacting quality life and visual function. Since detrimental immune response crucially responsible for development aggravation DED, therapeutic agents which modulate phenotype function eye-infiltrated cells could be used treatment severe DED. Due to their potent immunomodulatory properties, mesenchymal stem (MSCs) represent potentially new remedies diseases. The majority MSC-sourced bioactive factors are contained within MSC-derived exosomes (MSC-Exos), nano-sized extracellular vesicles which, due nanosize dimension lipid envelope, easily pass all biological barriers in body deliver cargo directly into target cells. MSC-Exos contain variety proteins (growth factors, immunoregulatory molecules, cytokines, chemokines) lipids, microRNAs (miRNAs) affect viability, proliferation, phenotype, Accordingly, may progression diseases, including Therefore, this review article, we summarized current knowledge regarding molecular cellular mechanisms were trophic, anti-inflammatory, immunoregulatory, regenerative properties For purpose, extensive literature was carried out February 2024 across several databases (Medline, Embase, Google Scholar), from 2000 present. Eligible studies delineated MSC-Exos-based modulation cell-driven inflammation findings analyzed review. Results obtained these demonstrated beneficial effects paving way future clinical use ophthalmology. Trial Registration: ClinicalTrials.gov identifier: NCT04213248, NCT06475027, NCT06543667, NCT05738629.

Язык: Английский

Mesenchymal Stem Cell–Sourced Exosomes as Potentially Novel Remedies for Severe Dry Eye Disease DOI Creative Commons

Carl Randall Harrell,

Valentin Djonov, Ana Volarevic

и другие.

Journal of Ophthalmology, Год журнала: 2025, Номер 2025(1)

Опубликована: Янв. 1, 2025

Severe dry eye disease (DED) is an inflammatory condition characterized by a lack of sufficient moisture or lubrication on the surface eye, significantly impacting quality life and visual function. Since detrimental immune response crucially responsible for development aggravation DED, therapeutic agents which modulate phenotype function eye-infiltrated cells could be used treatment severe DED. Due to their potent immunomodulatory properties, mesenchymal stem (MSCs) represent potentially new remedies diseases. The majority MSC-sourced bioactive factors are contained within MSC-derived exosomes (MSC-Exos), nano-sized extracellular vesicles which, due nanosize dimension lipid envelope, easily pass all biological barriers in body deliver cargo directly into target cells. MSC-Exos contain variety proteins (growth factors, immunoregulatory molecules, cytokines, chemokines) lipids, microRNAs (miRNAs) affect viability, proliferation, phenotype, Accordingly, may progression diseases, including Therefore, this review article, we summarized current knowledge regarding molecular cellular mechanisms were trophic, anti-inflammatory, immunoregulatory, regenerative properties For purpose, extensive literature was carried out February 2024 across several databases (Medline, Embase, Google Scholar), from 2000 present. Eligible studies delineated MSC-Exos-based modulation cell-driven inflammation findings analyzed review. Results obtained these demonstrated beneficial effects paving way future clinical use ophthalmology. Trial Registration: ClinicalTrials.gov identifier: NCT04213248, NCT06475027, NCT06543667, NCT05738629.

Язык: Английский

Процитировано

0